Marimed Inc. (MRMD) director converts 173,077 RSUs into common stock
Rhea-AI Filing Summary
MARIMED INC. director Eva M.D. Selhub received an equity award of 173,077 Restricted Stock Units on July 15, 2026 as part of her board fees. The RSUs vested immediately and converted one-for-one into 173,077 common shares, after which she directly owns 730,748 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 173,077 shares
Net Buy
3 txns
Insider
Selhub Eva M.D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (RSU) F1, F2 | 173,077 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units (RSU) F1, F2 | 173,077 | $0.00 | $0.00 |
| Exercise | Common stock F1 | 173,077 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units (RSU) — 0 shares (Direct);
Common stock — 730,748 shares (Direct)
Footnotes (2)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.
Key Figures
Common shares acquired: 173,077 shares
RSUs granted and vested: 173,077 units
Common shares owned after transaction: 730,748 shares
+1 more
4 metrics
Common shares acquired
173,077 shares
Shares of common stock received upon RSU conversion on July 15, 2026
RSUs granted and vested
173,077 units
Restricted Stock Units granted and vested upon grant on July 15, 2026
Common shares owned after transaction
730,748 shares
Direct MARIMED INC. common stock ownership after the July 15, 2026 award
Reported transaction price per share
0.0000 per share
Per-share value field for the RSU grant and conversion transactions
Key Terms
Restricted Stock Units (RSU), derivative security, vested upon grant
3 terms
Restricted Stock Units (RSU) financial
"Transaction lists security title as Restricted Stock Units (RSU) convertible into common stock"
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vested upon grant financial
"The RSUs were granted on July 15, 2026 and vested upon grant"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did MRMD director Eva M.D. Selhub report?
Eva M.D. Selhub reported an equity compensation transaction involving 173,077 Restricted Stock Units that converted into common shares. The RSUs vested immediately, resulting in her direct ownership of 730,748 MARIMED INC. common shares after the transaction.
Were the MRMD RSUs granted to Eva Selhub part of her board compensation?
Yes. The company states the RSUs were granted in lieu of cash for a portion of Eva Selhub’s board fees. This means she received equity instead of cash, with 173,077 RSUs vesting immediately and converting into the same number of common shares.
When did the RSU grant for MRMD director Eva Selhub vest and convert?
The RSUs granted to Eva Selhub on July 15, 2026 vested upon grant and converted on a one-for-one basis into common shares. According to the footnotes, no RSUs remain outstanding under this specific award after the conversion.
Did the MRMD Form 4 indicate any sales or gifts by Eva Selhub?
No sales or gifts were reported for Eva Selhub. The Form 4 shows RSUs being granted and then converted into 173,077 common shares, with no sale transactions, gifts, or tax-withholding dispositions disclosed in connection with this equity award.